Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group

Medical College of Virginia, Richmond 23298.

OBJECTIVES. This study examined patterns of implantable cardioverter-defibrillator use as documented by data logging. BACKGROUND. Implantable cardioverter-defibrillators are accepted therapy for malignant ventricular tachyarrhythmias; however, relatively little is known about their patterns of use. Incorporation of data-storage capacities into these devices provides insight into long-term defibrillator function. METHODS. Stored data-logging information was retrieved from 401 implanted cardioverter-defibrillators in 393 patients over an average of 303 days of follow-up. RESULTS. A total of 91,443 detections were recorded in 299 patients. One hundred-six patients (26%) had detections due to supraventricular tachycardias, electrical noise or other causes, resulting in inappropriate therapy delivery to 92 patients (23%). Two hundred eighty-one patients recorded 66,276 episodes of ventricular tachycardia or ventricular fibrillation. Of these, 74.4% episodes terminated spontaneously without any delivered therapy, 22.1% terminated after antitachycardia pacing, and 1.7% terminated after shock therapy. Antitachycardia pacing was activated without formal testing in 47% of all patients receiving this therapy and was successful in 96% of all episodes receiving this therapy. Acceleration of tachycardia to shock therapy occurred in 1.3% of all episodes and in 30.5% of patients receiving antitachycardia pacing. Thirty-four patients (8.7%) died during follow-up. Mortality was associated with patient age, heart failure functional class at implantation and frequency of shocks received during follow-up (all p < or = 0.05). CONCLUSIONS. Most ventricular tachyarrhythmia detections by this noncommitted implantable cardioverter-defibrillator resolve spontaneously, whereas the majority receiving therapy can be treated with antitachycardia pacing. Mortality after implantable cardioverter-defibrillator implantation is associated with age, heart failure class and frequency of shocks received during follow-up. Data-logging capabilities provide valuable insights into the patterns of defibrillator use.

This article has been cited by other articles:

				A. K. Gehi, D. Mehta, and J. A. Gomes Evaluation and Management of Patients After Implantable Cardioverter-Defibrillator Shock JAMA, December 20, 2006; 296(23): 2839 - 2847. [Abstract] [Full Text] [PDF]

				M. H. Gollob and J. J. Seger Current Status of the Implantable Cardioverter-Defibrillator Chest, April 1, 2001; 119(4): 1210 - 1221. [Abstract] [Full Text] [PDF]

				D. Bansch, D. Bocker, J.u. Brunn, M. Weber, G.u. Breithardt, and M. Block Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators J. Am. Coll. Cardiol., August 1, 2000; 36(2): 566 - 573. [Abstract] [Full Text] [PDF]

				A. Schaumann, F. v. z. Muhlen, B. Herse, B.-D. Gonska, and H. Kreuzer Empirical Versus Tested Antitachycardia Pacing in Implantable Cardioverter Defibrillators : A Prospective Study Including 200 Patients Circulation, January 13, 1998; 97(1): 66 - 74. [Abstract] [Full Text] [PDF]

				W. G. Stevenson, P. L. Friedman, and M. O. Sweeney Catheter Ablation as an Adjunct to ICD Therapy Circulation, September 2, 1997; 96(5): 1378 - 1380. [Full Text]

				J. Villacastin, J. Almendral, A. Arenal, J. Albertos, J. Ormaetxe, R. Peinado, H. Bueno, J. L. Merino, A. Pastor, O. Medina, et al. Incidence and Clinical Significance of Multiple Consecutive, Appropriate, High-Energy Discharges in Patients With Implanted Cardioverter-Defibrillators Circulation, February 15, 1996; 93(4): 753 - 762. [Abstract] [Full Text]

				G. H. Tofler, O. C. E. Gebara, M. A. Mittleman, P. Taylor, W. Siegel, F. J. Venditti Jr, C. A. Rasmussen, J. E. Muller, and f. t. C. Investigators Morning Peak in Ventricular Tachyarrhythmias Detected by Time of Implantable Cardioverter/Defibrillator Therapy Circulation, September 1, 1995; 92(5): 1203 - 1208. [Abstract] [Full Text]